SUNOCO LP (SUN) Spending and interest coverage
- R&D / revenue · 12 months: Value (m); Formula and calculation Research and development expense / revenue. Period ending 2026-06-30..
- Stock-based compensation / revenue · 12 months: Value 0.06%; Formula and calculation Share-based compensation / revenue. Period ending 2026-06-30..
- Interest coverage · 12 months: Value 2.69×; Formula and calculation Operating income ÷ reported interest expense..
Spending and interest coverage
Overview →Financial period ending 2026-06-30; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| R&D / revenue · 12 months | (m) | Research and development expense / revenue. Period ending 2026-06-30. Calculation unavailable: missing inputs remain (m). |
| Stock-based compensation / revenue · 12 months | 0.06% | Share-based compensation / revenue. Period ending 2026-06-30. $23.00M ÷ $39.58B × 100 ≈ 0.06% |
| Interest coverage · 12 months | 2.69× | Operating income ÷ reported interest expense. $1.89B ÷ $702.00M ≈ 2.69× |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Research and development spending | (m) | |
| Revenue | 39.58B USD | |
| Stock-based compensation | 23.00M USD | Share-based Payment Arrangement, Noncash Expense |
| Operating income | 1.89B USD | Operating Income (Loss) |
| Interest expense · reported / estimated | 702.00M USD | Interest Expense · Estimated expense assumptions |
Latest interest expense basis: Reported. Estimated values carry *; expand each history row’s basis for its dated balances and rate assumptions.
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Research and development spending (USD) | Revenue (USD) | Stock-based compensation (USD) | Operating income (USD) | Interest expense · reported / estimated (USD) | R&D / revenue | SBC / revenue | Interest coverage | Interest expense basis |
|---|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | (m) | $39.58B | $23.00M | $1.89B | $702.00M | (m) | 0.06% | 2.69× | Reported |
| 2026-03-31 | (m) | $30.71B | $21.00M | $1.50B | $621.00M | (m) | 0.07% | 2.42× | Reported |
| 2025-12-31 | (m) | $25.20B | $19.00M | $935.00M | $541.00M | (m) | 0.08% | 1.73× | Reported |
| 2025-09-30 | (m) | $21.87B | $19.00M | $988.00M | $492.00M | (m) | 0.09% | 2.01× | Reported |
| 2025-06-30 | (m) | $21.59B | $18.00M | $843.00M | $477.00M | (m) | 0.08% | 1.77× | Reported |
| 2025-03-31 | (m) | $22.37B | $17.00M | $790.00M | $449.00M | (m) | 0.08% | 1.76× | Reported |
| 2024-12-31 | (m) | $22.69B | $17.00M | $791.00M | $391.00M | (m) | 0.07% | 2.02× | Reported |
| 2024-09-30 | (m) | $23.07B | $16.00M | $511.00M | $329.00M | (m) | 0.07% | 1.55× | Reported |
| 2024-06-30 | (m) | $23.63B | $16.00M | $742.00M | $269.00M | (m) | 0.07% | 2.76× | Reported |
| 2024-03-31 | (m) | $23.20B | $16.00M | $733.00M | $227.00M | (m) | 0.07% | 3.23× | Reported |
| 2023-12-31 | (m) | $23.07B | $17.00M | $635.00M | $217.00M | (m) | 0.07% | 2.93× | Reported |
| 2023-09-30 | (m) | $23.34B | $15.00M | $774.00M | $209.00M | (m) | 0.06% | 3.70× | Reported |
| 2023-06-30 | (m) | $23.62B | $15.00M | $586.00M | $202.00M | (m) | 0.06% | 2.90× | Reported |
| 2023-03-31 | (m) | $25.69B | $14.00M | $618.00M | $194.00M | (m) | 0.05% | 3.19× | Reported |
| 2022-12-31 | (m) | $25.73B | $14.00M | $678.00M | $182.00M | (m) | 0.05% | 3.73× | Reported |
| 2022-09-30 | (m) | $24.77B | $16.00M | $758.00M | $174.00M | (m) | 0.06% | 4.36× | Reported |
| 2022-06-30 | (m) | $22.95B | $17.00M | $761.00M | $165.00M | (m) | 0.07% | 4.61× | Reported |
| 2022-03-31 | (m) | $19.53B | $17.00M | $804.00M | $163.00M | (m) | 0.09% | 4.93× | Reported |
| 2021-12-31 | (m) | $17.60B | $16.00M | $749.00M | $163.00M | (m) | 0.09% | 4.60× | Reported |
| 2021-09-30 | (m) | $15.20B | $15.00M | $717.00M | $168.00M | (m) | 0.10% | 4.27× | Reported |
| 2021-06-30 | (m) | $13.22B | $14.00M | $711.00M | $171.00M | (m) | 0.11% | 4.16× | Reported |
| 2021-03-31 | (m) | $10.91B | $14.00M | $703.00M | $172.00M | (m) | 0.13% | 4.09× | Reported |
| 2020-12-31 | (m) | $10.71B | $14.00M | $417.00M | $175.00M | (m) | 0.13% | 2.38× | Reported |
| 2020-09-30 | (m) | $12.26B | $14.00M | $371.00M | $174.00M | (m) | 0.11% | 2.13× | Reported |
| 2020-06-30 | (m) | $13.78B | $14.00M | $341.00M | $176.00M | (m) | 0.10% | 1.94× | Reported |
| 2020-03-31 | (m) | $16.18B | $14.00M | $230.00M | $175.00M | (m) | 0.09% | 1.31× | Reported |
| 2019-12-31 | (m) | $16.60B | $13.00M | $464.00M | $173.00M | (m) | 0.08% | 2.68× | Reported |
| 2019-09-30 | (m) | $16.38B | $12.00M | $328.00M | $171.00M | (m) | 0.07% | 1.92× | Reported |
| 2019-06-30 | (m) | $16.80B | $12.00M | $370.00M | $161.00M | (m) | 0.07% | 2.30× | Reported |
| 2019-03-31 | (m) | $16.94B | $12.00M | $401.00M | $154.00M | (m) | 0.07% | 2.60× | Reported |
| 2018-12-31 | (m) | $16.99B | $12.00M | $345.00M | $146.00M | (m) | 0.07% | 2.36× | Reported |
| 2018-09-30 | (m) | $17.51B | $16.00M | (m) | $132.00M | (m) | 0.09% | (m) | Reported |
| 2018-06-30 | (m) | $15.30B | $21.00M | (m) | $161.00M | (m) | 0.14% | (m) | Reported |
| 2018-03-31 | (m) | $12.66B | $23.00M | (m) | $181.00M | (m) | 0.18% | (m) | Reported |
| 2017-12-31 | (m) | $11.72B | $24.00M | $229.00M | $209.00M | (m) | 0.20% | 1.10× | Reported |
| 2017-09-30 | (m) | $9.71B | $22.00M | $155.00M | $211.00M | (m) | 0.23% | 0.73× | Reported |
| 2017-06-30 | (m) | $16.72B | $16.00M | $-349.00M | $236.00M | (m) | 0.10% | -1.48× | Reported |
| 2017-03-31 | (m) | $16.88B | $14.00M | $-292.00M | $225.00M | (m) | 0.08% | -1.30× | Reported |
| 2016-12-31 | (m) | $15.70B | $13.00M | $-248.00M | $189.00M | (m) | 0.08% | -1.31× | Reported |
| 2016-09-30 | (m) | $15.47B | $11.55M | $371.13M | $162.45M | (m) | 0.07% | 2.28× | Reported |
| 2016-06-30 | (m) | $16.24B | $11.02M | $360.33M | $136.68M | (m) | 0.07% | 2.64× | Reported |
| 2016-03-31 | (m) | $15.80B | $7.53M | $344.71M | $107.29M | (m) | 0.05% | 3.21× | Reported |
| 2015-12-31 | (m) | $16.94B | $5.70M | $318.25M | $87.58M | (m) | 0.03% | 3.63× | Reported |
| 2015-09-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2015-06-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2015-03-31 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2014-12-31 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2014-09-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2014-06-30 | (m) | $4.87B | $2.61M | $44.56M | $5.30M | (m) | 0.05% | 8.41× | Reported |
| 2014-03-31 | (m) | $4.62B | $2.24M | $43.60M | $4.29M | (m) | 0.05% | 10.16× | Reported |
| 2013-12-31 | (m) | $4.49B | $1.94M | $40.94M | $3.47M | (m) | 0.04% | 11.79× | Reported |
| 2013-09-30 | (m) | $4.37B | $636.00K | $39.48M | $2.89M | (m) | 0.01% | 13.68× | Reported |
| 2013-06-30 | (m) | $4.32B | (m) | $34.29M | $2.08M | (m) | (m) | 16.50× | Reported |
| 2013-03-31 | (m) | $4.29B | (m) | $29.66M | (m) | (m) | (m) | (m) | (m) |
| 2012-12-31 | (m) | $4.28B | $101.00K | $23.41M | $809.00K | (m) | 0.00% | 28.94× | Reported |
| 2012-09-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2012-06-30 | (m) | $4.12B | (m) | $16.99M | (m) | (m) | (m) | (m) | (m) |
| 2012-03-31 | (m) | $4.04B | (m) | $16.69M | (m) | (m) | (m) | (m) | (m) |
| 2011-12-31 | (m) | $3.82B | (m) | $16.96M | (m) | (m) | (m) | (m) | (m) |
| 2011-09-30 | (m) | $3.57B | (m) | $17.49M | (m) | (m) | (m) | (m) | (m) |
| 2011-06-30 | (m) | $3.22B | (m) | $16.88M | (m) | (m) | (m) | (m) | (m) |
| 2011-03-31 | (m) | $2.90B | (m) | $15.40M | (m) | (m) | (m) | (m) | (m) |
| 2010-12-31 | (m) | $2.68B | (m) | $14.74M | (m) | (m) | (m) | (m) | (m) |
| 2010-09-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2010-06-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2010-03-31 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.